Tag : Olopatadine Hydrochloride Ophthalmic Solution

Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC)

NewsmantraAugust 20, 2024

Bengaluru, August 19, 2024: Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce it has launched1 Olopatadine Hydrochloride...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More